Cointime

  • Новости
  • заголовки
  • Кавычки
  • Столбец
  • Активность
  • Bitcoin $61,352.72 +1.71%
  • Ethereum $1,701.95 +5.08%
  • BNB $560.10 +1.72%
  • Optimism $0.10 +4.16%
  • Arbitrum $0.08 +0.96%
  • Solana $80.73 +3.10%
  • Polygon $0.22 +2.77%
  • Cosmos $1.56 +0.52%
  • Avalanche $6.84 +2.48%
  • Bitcoin $61,352.72 +1.71%
  • Ethereum $1,701.95 +5.08%
  • BNB $560.10 +1.72%
  • Optimism $0.10 +4.16%
  • Arbitrum $0.08 +0.96%
  • Solana $80.73 +3.10%
  • Polygon $0.22 +2.77%
  • Cosmos $1.56 +0.52%
  • Avalanche $6.84 +2.48%
Home / X4 Pharmaceuticals / investors

X4 Pharmaceuticals

company

Investors

Number of Lead Investors
Number of Investors
5
17
X4 Pharmaceuticals is funded by 17 investors. Acorn Bioventures and Lumira Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Acorn Bioventures Yes Post-IPO Equity
Lumira Ventures Yes Post-IPO Equity
New Enterprise Associates Yes Post-IPO Equity
Cormorant Asset Management Yes Series B
Hercules Capital - Post-IPO Equity
AXA Investment Managers - Post-IPO Equity
Bain Capital Life Sciences - Post-IPO Equity
OrbiMed - Post-IPO Equity
Abingworth - Post-IPO Equity
Altium Capital - Post-IPO Equity
Driehaus Capital Management - Post-IPO Equity
Ikarian Capital - Post-IPO Equity
Lincoln Park Capital Fund - Post-IPO Equity
Monashee Investment Management - Post-IPO Equity
Sio Capital Management - Post-IPO Equity
Thynk Capital, LLC. - Series A
SV Health Investors - Seed

Contact

Cambridge,Massachusetts,United States
+1 857 529 8300
Cointime
Содержание
  • Новости
  • венчурный капитал
  • Отраслевые исследования
  • наука и технология
  • Активность
компания
  • о нас
  • Рекламное сотрудничество
  • Отказ от ответственности
  • © 2023 Cointime. все права защищены
  • политика конфиденциальности
  • Условия использования